The Australian Ovarian Cancer Study (AOCS) is a collaborative research program between clinicians, scientists, patients and advocacy groups, aimed at improving the prevention, diagnosis and treatment of ovarian cancer.
Initiated in 2001 by researchers at Peter Mac, University of Melbourne, Queensland Institute of Medical Research and Westmead Institute for Medical Research, the first goal of the AOCS was to create a uniquely powerful resource for ovarian cancer research, comprising biospecimens, clinical outcome and epidemiological data. A total of 2456 women from all Australian states have consented to take part in the study. The AOCS Biobank provides researchers access to DNA, RNA, plasma, serum, fresh-frozen tissue, FFPE blocks and tissue microarrays (TMAs), as well as matched clinical and epidemiological data. To date, we have approved 104 national and international projects.